share_log

12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga ·  04:31

Gainers

  • Repare Therapeutics (NASDAQ:RPTX) stock increased by 13.4% to $3.9 during Monday's after-market session. The company's market cap stands at $165.5 million.
  • Cognition Therapeutics (NASDAQ:CGTX) shares moved upwards by 10.45% to $0.52. The company's market cap stands at $20.7 million.
  • Singular Genomics Sys (NASDAQ:OMIC) shares rose 9.76% to $17.2. The company's market cap stands at $42.9 million.
  • Vor Biopharma (NASDAQ:VOR) shares increased by 5.81% to $0.74. The company's market cap stands at $50.6 million.
  • Bionano Genomics (NASDAQ:BNGO) stock moved upwards by 5.75% to $0.48. The market value of their outstanding shares is at $41.2 million.
  • Quantum-Si (NASDAQ:QSI) shares increased by 5.41% to $0.93. The company's market cap stands at $132.3 million.

Losers

  • IGM Biosciences (NASDAQ:IGMS) shares decreased by 15.4% to $14.0 during Monday's after-market session. The market value of their outstanding shares is at $830.4 million.
  • Karyopharm Therapeutics (NASDAQ:KPTI) stock decreased by 9.4% to $0.75. The market value of their outstanding shares is at $93.7 million.
  • Pennant Gr (NASDAQ:PNTG) stock decreased by 7.57% to $33.0. The company's market cap stands at $996.8 million.
  • Apollomics (NASDAQ:APLM) stock decreased by 6.26% to $0.13. The market value of their outstanding shares is at $14.6 million.
  • NewGenIvf Group (NASDAQ:NIVF) stock decreased by 5.0% to $0.65. The company's market cap stands at $6.5 million.
  • Cue Biopharma (NASDAQ:CUE) stock decreased by 5.0% to $0.72. The market value of their outstanding shares is at $34.9 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment